OBJECTIVE: Peripherally inserted central catheter (PICC) tip malposition is potentially associated with complications, and postplacement adjustment of PICCs is widely performed. We sought to characterize the association between central line-associated bloodstream infection (CLABSI) or venous thrombus (VT) and PICC adjustment. DESIGN: Retrospective cohort study. SETTING: University of Michigan Health System, a large referral hospital. PATIENTS: Patients who had PICCs placed between February 2007 and August 2007. METHODS: The primary outcomes were development of CLABSI within 14 days or VT within 60 days of postplacement PICC adjustment, identified by review of patient electronic medical records. RESULTS: There were 57 CLABSIs (2.69/1,000 PICC-days) and 47 VTs (1.23/1,000 PICC-days); 609 individuals had 1, 134 had 2, and 33 had 3 or more adjustments. One adjustment was protective against CLABSI (P=.04), whereas 2 or 3 or more adjustments had no association with CLABSI (P=.58 and .47, respectively). One, 2, and 3 or more adjustments had no association with VT formation (P=.59, .85, and .78, respectively). Immunosuppression (P<.01), power-injectable PICCs (P=.05), and 3 PICC lumens compared with 1 lumen (P=.02) were associated with CLABSI. Power-injectable PICCs were also associated with increased VT formation (P=.03). CONCLUSIONS: Immunosuppression and 3 PICC lumens were associated with increased risk of CLABSI. Power-injectable PICCs were associated with increased risk of CLABSI and VT formation. Postplacement adjustment of PICCs was not associated with increased risk of CLABSI or VT.
OBJECTIVE: Peripherally inserted central catheter (PICC) tip malposition is potentially associated with complications, and postplacement adjustment of PICCs is widely performed. We sought to characterize the association between central line-associated bloodstream infection (CLABSI) or venous thrombus (VT) and PICC adjustment. DESIGN: Retrospective cohort study. SETTING: University of Michigan Health System, a large referral hospital. PATIENTS: Patients who had PICCs placed between February 2007 and August 2007. METHODS: The primary outcomes were development of CLABSI within 14 days or VT within 60 days of postplacement PICC adjustment, identified by review of patient electronic medical records. RESULTS: There were 57 CLABSIs (2.69/1,000 PICC-days) and 47 VTs (1.23/1,000 PICC-days); 609 individuals had 1, 134 had 2, and 33 had 3 or more adjustments. One adjustment was protective against CLABSI (P=.04), whereas 2 or 3 or more adjustments had no association with CLABSI (P=.58 and .47, respectively). One, 2, and 3 or more adjustments had no association with VT formation (P=.59, .85, and .78, respectively). Immunosuppression (P<.01), power-injectable PICCs (P=.05), and 3 PICC lumens compared with 1 lumen (P=.02) were associated with CLABSI. Power-injectable PICCs were also associated with increased VT formation (P=.03). CONCLUSIONS: Immunosuppression and 3 PICC lumens were associated with increased risk of CLABSI. Power-injectable PICCs were associated with increased risk of CLABSI and VT formation. Postplacement adjustment of PICCs was not associated with increased risk of CLABSI or VT.
Authors: R Scott Evans; Jamie H Sharp; Lorraine H Linford; James F Lloyd; Jacob S Tripp; Jason P Jones; Scott C Woller; Scott M Stevens; C Gregory Elliott; Lindell K Weaver Journal: Chest Date: 2010-10 Impact factor: 9.410
Authors: Scott O Trerotola; S William Stavropoulos; Jeffrey I Mondschein; Aalpen A Patel; Neil Fishman; Barry Fuchs; Daniel M Kolansky; Scott Kasner; John Pryor; Jesse Chittams Journal: Radiology Date: 2010-07 Impact factor: 11.105
Authors: Arnab Sengupta; Christoph Lehmann; Marie Diener-West; Trish M Perl; Aaron M Milstone Journal: Pediatrics Date: 2010-03-15 Impact factor: 7.124
Authors: Manuela Bonizzoli; Stefano Batacchi; Giovanni Cianchi; Giovanni Zagli; Francesco Lapi; Valentina Tucci; Giacomo Martini; Simona Di Valvasone; Adriano Peris Journal: Intensive Care Med Date: 2010-09-21 Impact factor: 17.440
Authors: M Cristina Ajenjo; James C Morley; Anthony J Russo; Kathleen M McMullen; Catherine Robinson; Robert C Williams; David K Warren Journal: Infect Control Hosp Epidemiol Date: 2011-02 Impact factor: 3.254
Authors: Paula Parás-Bravo; María Paz-Zulueta; Raquel Sarabia-Lavin; Francisco Jose Amo-Setién; Manuel Herrero-Montes; Encarnación Olavarría-Beivíde; Mercedes Rodríguez-Rodríguez; Blanca Torres-Manrique; Carlos Rodríguez-de la Vega; Vanesa Caso-Álvarez; Laura González-Parralo; Francisco Manuel Antolín-Juárez Journal: PLoS One Date: 2016-09-02 Impact factor: 3.240
Authors: Simon Bessis; Nadim Cassir; Line Meddeb; Anne Bonnet Remacle; Jérôme Soussan; Vincent Vidal; Pierre-Edouard Fournier; Florence Fenollar; Didier Raoult; Philippe Brouqui Journal: Medicine (Baltimore) Date: 2020-01 Impact factor: 1.817